![]()
GONUTS is under stress! The website is currently experiencing long-wait times and frequent time-outs due to the record number of students, groups, and annotations related to CACAO this semester. We are currently working on increasing performance -- please accept our apologies for the technical difficulties.
You can help reduce stress on the server by:
- not reloading pages frequently - this just adds
- opening links in new windows (so you can read the old page)
HUMAN:TNAP3
Contents |
| Species (Taxon ID) | Homo sapiens (Human). (taxon:9606) | |
| Gene Name(s) | TNFAIP3 ( synonyms: OTUD7C ) | |
| Protein Name(s) |
| |
| External Links | ||
| UniProt Identifier | TNAP3_HUMAN | |
| UniProt Accessions | P21580, B2R767, E1P588, Q2HIX9, Q5VXQ7, Q9NSR6, | |
| EMBL | M59465, AK312862, AY248754, AL357060, CH471051, CH471051, BC113871, BC114480, AL157444, | |
| PIR | A35797, | |
| RefSeq | NP_006281.1, | |
| PDB | 2EQE, 2EQF, 2EQG, 2VFJ, 3DKB, 3OJ3, 3OJ4, | |
| IntAct | P21580, | |
| Ensembl | ENST00000237289, | |
| Pfam | PF02338, PF01754, | |
Annotations
| Qualifier | GO ID | GO term name | Reference | Evidence Code | with/from | Aspect | Notes | Status |
|---|---|---|---|---|---|---|---|---|
| GO:0032480 |
negative regulation of type I interferon production |
Reactome:REACT_25271 |
TAS: Traceable Author Statement |
|
P |
|||
| GO:0070936 |
protein K48-linked ubiquitination |
IDA: Inferred from Direct Assay |
|
P |
||||
| GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB cascade |
IDA: Inferred from Direct Assay |
|
P |
||||
| GO:0002634 |
regulation of germinal center formation |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0002237 |
response to molecule of bacterial origin |
IDA: Inferred from Direct Assay |
|
P |
||||
| GO:0005813 |
centrosome |
IDA: Inferred from Direct Assay |
|
C |
||||
| GO:0005737 |
cytoplasm |
IEA: Inferred from Electronic Annotation |
C |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0008270 |
zinc ion binding |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0006915 |
apoptosis |
IEA: Inferred from Electronic Annotation |
P |
|||||
| GO:0051259 |
protein oligomerization |
NAS: Non-traceable Author Statement |
|
P |
||||
| GO:0004221 |
ubiquitin thiolesterase activity |
IMP: Inferred from Mutant Phenotype |
|
F |
||||
| GO:0046872 |
metal ion binding |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0004843 |
ubiquitin-specific protease activity |
TAS: Traceable Author Statement |
|
F |
||||
| GO:0016787 |
hydrolase activity |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0090291 |
negative regulation of osteoclast proliferation |
NAS: Non-traceable Author Statement |
|
P |
||||
| GO:0071222 |
cellular response to lipopolysaccharide |
IDA: Inferred from Direct Assay |
|
P |
||||
| GO:0045732 |
positive regulation of protein catabolic process |
IDA: Inferred from Direct Assay |
|
P |
||||
| GO:0008152 |
metabolic process |
IEA: Inferred from Electronic Annotation |
P |
|||||
| GO:2000349 |
negative regulation of CD40 signaling pathway |
IMP: Inferred from Mutant Phenotype |
|
P |
||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0005634 |
nucleus |
IDA: Inferred from Direct Assay |
|
C |
||||
| GO:0003824 |
catalytic activity |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0016874 |
ligase activity |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0061043 |
regulation of vascular wound healing |
NAS: Non-traceable Author Statement |
|
P |
||||
| GO:0016579 |
protein deubiquitination |
TAS: Traceable Author Statement |
|
P |
||||
| GO:0031397 |
negative regulation of protein ubiquitination |
IDA: Inferred from Direct Assay |
|
P |
||||
| GO:0005634 |
nucleus |
IEA: Inferred from Electronic Annotation |
SP_SL:SL-0191 |
C |
||||
| GO:0072573 |
tolerance induction to lipopolysaccharide |
IMP: Inferred from Mutant Phenotype |
|
P |
||||
| GO:2000352 |
negative regulation of endothelial cell apoptosis |
IDA: Inferred from Direct Assay |
|
P |
||||
| GO:0032088 |
negative regulation of NF-kappaB transcription factor activity |
IDA: Inferred from Direct Assay |
|
P |
||||
| GO:0043130 |
ubiquitin binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0050869 |
negative regulation of B cell activation |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0071222 |
cellular response to lipopolysaccharide |
IDA: Inferred from Direct Assay |
|
P |
||||
| GO:0032720 |
negative regulation of tumor necrosis factor production |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0003677 |
DNA binding |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB cascade |
IDA: Inferred from Direct Assay |
|
P |
||||
| GO:0003677 |
DNA binding |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0050691 |
regulation of defense response to virus by host |
NAS: Non-traceable Author Statement |
|
P |
||||
| GO:0001922 |
B-1 B cell homeostasis |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0006916 |
anti-apoptosis |
IDA: Inferred from Direct Assay |
|
P |
||||
| GO:0070536 |
protein K63-linked deubiquitination |
IDA: Inferred from Direct Assay |
|
P |
||||
| GO:0005737 |
cytoplasm |
IEA: Inferred from Electronic Annotation |
Ensembl:ENSMUSP00000019997 |
C |
||||
| GO:0006916 |
anti-apoptosis |
NAS: Non-traceable Author Statement |
|
P |
||||
| GO:0008233 |
peptidase activity |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0034140 |
negative regulation of toll-like receptor 3 signaling pathway |
IDA: Inferred from Direct Assay |
|
P |
||||
| GO:0005829 |
cytosol |
EXP: Inferred from Experiment |
|
C |
||||
| GO:0043621 |
protein self-association |
IDA: Inferred from Direct Assay |
|
F |
||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0034136 |
negative regulation of toll-like receptor 2 signaling pathway |
NAS: Non-traceable Author Statement |
|
P |
||||
| GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB cascade |
IDA: Inferred from Direct Assay |
|
P |
||||
| GO:0005737 |
cytoplasm |
IDA: Inferred from Direct Assay |
|
C |
||||
| GO:0045779 |
negative regulation of bone resorption |
NAS: Non-traceable Author Statement |
|
P |
||||
| GO:0034144 |
negative regulation of toll-like receptor 4 signaling pathway |
NAS: Non-traceable Author Statement |
|
P |
||||
| GO:0002020 |
protease binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0043027 |
caspase inhibitor activity |
NAS: Non-traceable Author Statement |
|
F |
||||
| GO:0005737 |
cytoplasm |
IEA: Inferred from Electronic Annotation |
SP_SL:SL-0086 |
C |
||||
| GO:0032715 |
negative regulation of interleukin-6 production |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0050728 |
negative regulation of inflammatory response |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0071222 |
cellular response to lipopolysaccharide |
IDA: Inferred from Direct Assay |
|
P |
||||
| GO:0005634 |
nucleus |
IEA: Inferred from Electronic Annotation |
C |
|||||
| GO:0004842 |
ubiquitin-protein ligase activity |
IDA: Inferred from Direct Assay |
|
F |
||||
| GO:0043621 |
protein self-association |
IDA: Inferred from Direct Assay |
|
F |
||||
| GO:0008234 |
cysteine-type peptidase activity |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0004843 |
ubiquitin-specific protease activity |
IDA: Inferred from Direct Assay |
|
F |
||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0032703 |
negative regulation of interleukin-2 production |
IMP: Inferred from Mutant Phenotype |
|
P |
||||
| GO:0043154 |
negative regulation of caspase activity |
IDA: Inferred from Direct Assay |
|
P |
||||
| GO:0048662 |
negative regulation of smooth muscle cell proliferation |
IDA: Inferred from Direct Assay |
|
P |
||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0001922 |
B-1 B cell homeostasis |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0002020 |
protease binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0002218 |
activation of innate immune response |
Reactome:REACT_75913 |
TAS: Traceable Author Statement |
P |
||||
| GO:0002237 |
response to molecule of bacterial origin |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0002634 |
regulation of germinal center formation |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0003677 |
DNA binding |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0003677 |
DNA binding |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0003824 |
catalytic activity |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0004221 |
ubiquitin thiolesterase activity |
IMP: Inferred from Mutant Phenotype |
F |
|||||
| GO:0004842 |
ubiquitin-protein ligase activity |
IDA: Inferred from Direct Assay |
F |
|||||
| GO:0004843 |
ubiquitin-specific protease activity |
IDA: Inferred from Direct Assay |
F |
|||||
| GO:0004843 |
ubiquitin-specific protease activity |
TAS: Traceable Author Statement |
F |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0005515 |
protein binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0005634 |
nucleus |
IEA: Inferred from Electronic Annotation |
C |
|||||
| GO:0005634 |
nucleus |
IEA: Inferred from Electronic Annotation |
SP_SL:SL-0191 |
C |
||||
| GO:0005634 |
nucleus |
IDA: Inferred from Direct Assay |
C |
|||||
| GO:0005737 |
cytoplasm |
IEA: Inferred from Electronic Annotation |
C |
|||||
| GO:0005737 |
cytoplasm |
IEA: Inferred from Electronic Annotation |
Ensembl:ENSMUSP00000019997 |
C |
||||
| GO:0005737 |
cytoplasm |
IEA: Inferred from Electronic Annotation |
SP_SL:SL-0086 |
C |
||||
| GO:0005737 |
cytoplasm |
IDA: Inferred from Direct Assay |
C |
|||||
| GO:0005813 |
centrosome |
IDA: Inferred from Direct Assay |
C |
|||||
| GO:0005829 |
cytosol |
Reactome:REACT_25179 |
TAS: Traceable Author Statement |
C |
||||
| GO:0005829 |
cytosol |
Reactome:REACT_75888 |
TAS: Traceable Author Statement |
C |
||||
| GO:0006915 |
apoptosis |
IEA: Inferred from Electronic Annotation |
P |
|||||
| GO:0006916 |
anti-apoptosis |
NAS: Non-traceable Author Statement |
P |
|||||
| GO:0006916 |
anti-apoptosis |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0008152 |
metabolic process |
IEA: Inferred from Electronic Annotation |
P |
|||||
| GO:0008233 |
peptidase activity |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0008234 |
cysteine-type peptidase activity |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0008270 |
zinc ion binding |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0016579 |
protein deubiquitination |
TAS: Traceable Author Statement |
P |
|||||
| GO:0016787 |
hydrolase activity |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0016874 |
ligase activity |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0031397 |
negative regulation of protein ubiquitination |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0032088 |
negative regulation of NF-kappaB transcription factor activity |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0032480 |
negative regulation of type I interferon production |
Reactome:REACT_25271 |
TAS: Traceable Author Statement |
P |
||||
| GO:0032703 |
negative regulation of interleukin-2 production |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0032715 |
negative regulation of interleukin-6 production |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0032720 |
negative regulation of tumor necrosis factor production |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0034136 |
negative regulation of toll-like receptor 2 signaling pathway |
NAS: Non-traceable Author Statement |
P |
|||||
| GO:0034140 |
negative regulation of toll-like receptor 3 signaling pathway |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0034144 |
negative regulation of toll-like receptor 4 signaling pathway |
NAS: Non-traceable Author Statement |
P |
|||||
| GO:0043027 |
caspase inhibitor activity |
NAS: Non-traceable Author Statement |
F |
|||||
| GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB cascade |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB cascade |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB cascade |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0043130 |
ubiquitin binding |
IPI: Inferred from Physical Interaction |
F |
|||||
| GO:0043154 |
negative regulation of caspase activity |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0043154 |
negative regulation of caspase activity |
NAS: Non-traceable Author Statement |
P |
|||||
| GO:0043621 |
protein self-association |
IDA: Inferred from Direct Assay |
F |
|||||
| GO:0043621 |
protein self-association |
IDA: Inferred from Direct Assay |
F |
|||||
| GO:0045087 |
innate immune response |
Reactome:REACT_6802 |
TAS: Traceable Author Statement |
P |
||||
| GO:0045732 |
positive regulation of protein catabolic process |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0045779 |
negative regulation of bone resorption |
NAS: Non-traceable Author Statement |
P |
|||||
| GO:0046872 |
metal ion binding |
IEA: Inferred from Electronic Annotation |
F |
|||||
| GO:0048662 |
negative regulation of smooth muscle cell proliferation |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0050691 |
regulation of defense response to virus by host |
NAS: Non-traceable Author Statement |
P |
|||||
| GO:0050728 |
negative regulation of inflammatory response |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0050869 |
negative regulation of B cell activation |
ISS: Inferred from Sequence or Structural Similarity |
P |
|||||
| GO:0051259 |
protein oligomerization |
NAS: Non-traceable Author Statement |
P |
|||||
| GO:0061043 |
regulation of vascular wound healing |
NAS: Non-traceable Author Statement |
P |
|||||
| GO:0070423 |
nucleotide-binding oligomerization domain containing signaling pathway |
Reactome:REACT_75776 |
TAS: Traceable Author Statement |
P |
||||
| GO:0070536 |
protein K63-linked deubiquitination |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0070936 |
protein K48-linked ubiquitination |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0071222 |
cellular response to lipopolysaccharide |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0071222 |
cellular response to lipopolysaccharide |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0071222 |
cellular response to lipopolysaccharide |
IDA: Inferred from Direct Assay |
P |
|||||
| GO:0072573 |
tolerance induction to lipopolysaccharide |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:0090291 |
negative regulation of osteoclast proliferation |
NAS: Non-traceable Author Statement |
P |
|||||
| GO:2000349 |
negative regulation of CD40 signaling pathway |
IMP: Inferred from Mutant Phenotype |
P |
|||||
| GO:2000352 |
negative regulation of endothelial cell apoptosis |
IDA: Inferred from Direct Assay |
P |
| ||||
| edit table |
Notes
References
See Help:References for how to manage references in GONUTS.
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 Wertz IE et al. (2004) De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430: 694-9 PubMed GONUTS page
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 2.6 2.7 Evans PC et al. (2001) Isolation and characterization of two novel A20-like proteins. Biochem J 357: 617-23 PubMed GONUTS page
- ↑ 3.0 3.1 3.2 3.3 Oshima N et al. (2010) A20 is an early responding negative regulator of Toll-like receptor 5 signalling in intestinal epithelial cells during inflammation. Clin Exp Immunol 159: 185-98 PubMed GONUTS page
- ↑ 4.0 4.1 4.2 4.3 Barbe L et al. (2008) Toward a confocal subcellular atlas of the human proteome. Mol Cell Proteomics 7: 499-508 PubMed GONUTS page
- ↑ 5.00 5.01 5.02 5.03 5.04 5.05 5.06 5.07 5.08 5.09 5.10 5.11 5.12 5.13 Wang YY et al. (2004) A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-kappaB and ISRE and IFN-beta promoter. FEBS Lett 576: 86-90 PubMed GONUTS page
- ↑ 6.0 6.1 6.2 6.3 6.4 6.5 6.6 6.7 Ning S & Pagano JS (2010) The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7. J Virol 84: 6130-8 PubMed GONUTS page
- ↑ 7.0 7.1 7.2 7.3 7.4 7.5 7.6 7.7 7.8 7.9 Mabilleau G et al. (2011) Role of the A20-TRAF6 axis in lipopolysaccharide-mediated osteoclastogenesis. J Biol Chem 286: 3242-9 PubMed GONUTS page
- ↑ 8.0 8.1 8.2 8.3 Longo CR et al. (2003) A20 protects from CD40-CD40 ligand-mediated endothelial cell activation and apoptosis. Circulation 108: 1113-8 PubMed GONUTS page
- ↑ 9.0 9.1 9.2 9.3 Patel VI et al. (2006) A20, a modulator of smooth muscle cell proliferation and apoptosis, prevents and induces regression of neointimal hyperplasia. FASEB J 20: 1418-30 PubMed GONUTS page
- ↑ 10.0 10.1 10.2 10.3 Xiong Y et al. (2011) Endotoxin tolerance impairs IL-1 receptor-associated kinase (IRAK) 4 and TGF-beta-activated kinase 1 activation, K63-linked polyubiquitination and assembly of IRAK1, TNF receptor-associated factor 6, and IkappaB kinase gamma and increases A20 expression. J Biol Chem 286: 7905-16 PubMed GONUTS page
- ↑ 11.0 11.1 11.2 11.3 11.4 11.5 Coornaert B et al. (2008) T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20. Nat Immunol 9: 263-71 PubMed GONUTS page
- ↑ 12.0 12.1 Fenner BJ et al. (2009) Identification of polyubiquitin binding proteins involved in NF-kappaB signaling using protein arrays. Biochim Biophys Acta 1794: 1010-6 PubMed GONUTS page
- ↑ 13.0 13.1 13.2 13.3 13.4 13.5 13.6 13.7 Gon Y et al. (2004) A20 inhibits toll-like receptor 2- and 4-mediated interleukin-8 synthesis in airway epithelial cells. Am J Respir Cell Mol Biol 31: 330-6 PubMed GONUTS page
- ↑ 14.0 14.1 14.2 14.3 14.4 14.5 14.6 He KL & Ting AT (2002) A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells. Mol Cell Biol 22: 6034-45 PubMed GONUTS page
- ↑ Parvatiyar K et al. (2010) TAX1BP1 and A20 inhibit antiviral signaling by targeting TBK1-IKKi kinases. J Biol Chem 285: 14999-5009 PubMed GONUTS page
- ↑ 16.0 16.1 De Valck D et al. (1996) A20, an inhibitor of cell death, self-associates by its zinc finger domain. FEBS Lett 384: 61-4 PubMed GONUTS page
- ↑ 17.0 17.1 Lang V et al. (2004) ABIN-2 forms a ternary complex with TPL-2 and NF-kappa B1 p105 and is essential for TPL-2 protein stability. Mol Cell Biol 24: 5235-48 PubMed GONUTS page